newsfilter
← Latest News
PR Newswire·

MYND Life Sciences Announces Collaborative Research Agreement with the University of British Columbia

MYND's Second CRA focuses on Novel Therapies for Neurological Diseases of the Brain VANCOUVER, BC, Jan. 12, 2022 /PRNewswire/ - MYND Life Sciences Inc. ("MYND" or the "Company") (CSE:MYND) (OTC:MYNDF) a biopharmaceutical research and development c